Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: This presentation is from session number 2, presented at the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists discuss current statutory valuation issues pertaining to life and annuity products. They provide updates on the Unified Valuation Law [UVL] Task Force, equity-indexed products [including NAIC actuarial guidelines ZZZ and ZZZZ], NAIC actuarial guidelines XXXIII and XXXIV, variable annuity guaranteed living benefits VAGLB, the NAIC Model Regulation for Group Annuity Separate Accounts, Actuarial Opinion and Memorandum Regulation [AOMR] revisions, and other current topics.

Description: 1999 SOA Annual Meeting, San Francisco. This panel discussion dealt with several new product types and the accounting profession's efforts to provide guidance. The five product types below do not fit neatly into the rules set forth in Statement of Financial Accounting Standards 50 and 97: 1. Variable annuities with guaranteed living benefits. 2. Equity-indexed products. 3. Market-value-adjusted annuities. 4. Annuities with a front-end bonus feature. 5. Investment contracts with no significant source of profit other than interest spread.

Description: This presentation is a panel discussion, session number 2PD, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The panelists provide an overview of current statutory valuation issues pertaining to life and annuity products, to be covered in-depth at subsequent sessions. Topics include: new valuation table for life insurance NAIC Actuarial Guidelines [AG] for variable product guaranteed living benefits and for equity-indexed universal life [ZZZZ] amendments to the Actuarial Opinion and Memorandum Regulation [AOMR] progress on Unified Valuation System [UVS] Model Regulations on Separate Accounts Funding Group Contracts with Guarantees, and on Synthetic Guaranteed Investment Contracts [GICs] regulatory concern over liquidity and Regulation XXX mortality X factors.

Description: This session at the 2004 Valuation Actuary Symposium provides an overview of statutory valuation issues for life and annuity products including the Actuarial Opinion and Memorandum Regulation, variable products reserving standard, adoption of 2001 CSO, C-3 Phase II RBC project and nonforfeiture changes.